Artificial Intelligence and Data Mining Methods for Cardiovascular Risk Prediction

Fuzzy entropy DEMATEL inference system for accurate and efficient cardiovascular disease diagnosis

The global population is at risk from both communicable and non-communicable deadly diseases, including cardiovascular disease. Early detection and prevention of cardiovascular disease require an accurate self-detection model. Therefore, this study introduces a novel fuzzy entropy DEMATEL inference system for accurate self-detection of cardiovascular disease. It combines fuzzy DEMATEL, entropy, and Mamdani fuzzy inference, utilizing innovative strategies like attribute reduction, entropy-based clustering, influential factor selection, and rule reduction. The system achieves high accuracy (98.69%) and sensitivity (98.62%), outperforming existing methods. Validation includes satisfactory factor analysis, performance measures and statistical analysis, demonstrating its effectiveness in addressing complexity and prioritizing factors.

Review on Emerging Therapeutic Strategies for Managing Cardiovascular Disease

Cardiovascular disease (CVD) remains a foremost global health concern, necessitating ongoing exploration of innovative therapeutic strategies. This review surveys the latest developments in cardiovascular therapeutics, offering a comprehensive overview of emerging approaches poised to transform disease management. The examination begins by elucidating the current epidemiological landscape of CVD and the economic challenges it poses to healthcare systems. It proceeds to scrutinize the limitations of traditional therapies, emphasizing the need for progressive interventions. The core focus is on novel pharmacological interventions, including advancements in drug development, targeted therapies, and repurposing existing medications. The burgeoning field of gene therapy and its potential in addressing genetic predispositions to cardiovascular disorders are explored, alongside the integration of artificial intelligence and machine learning in risk assessment and treatment optimization. Non-pharmacological interventions take center stage, with an exploration of digital health technologies, wearable devices, and telemedicine as transformative tools in CVD management. Regenerative medicine and stem cell therapies, offering promises of tissue repair and functional recovery, are investigated for their potential impact on cardiac health. This review also delves into the interplay of lifestyle modifications, diet, exercise, and behavioral changes, emphasizing their pivotal role in cardiovascular health and disease prevention. As precision medicine gains prominence, this synthesis of emerging therapeutic modalities aims to guide clinicians and researchers in navigating the dynamic landscape of cardiovascular disease management, fostering a collective effort to alleviate the global burden of CVD and promote a healthier future.

Graph-guided Gaussian Process-based Diagnosis of CVD Severity with Uncertainty Measures

The severity of coronary artery disease can be assessed invasively using the Fractional Flow Reserve (FFR) index which is a useful diagnostic tool for the clinicians to select the treatment approach. The present work capitalizes a Gaussian process (GP) framework over graphs for the prediction of FFR index using only non-invasive imaging and clinical features. More specifically, taking the per-node one-hop connectivity vector as input, we employed a regression-based task by applying an ensemble of graph-adapted Gaussian process experts, with a data-adaptive fashion via online training. The main novelty of the work lies in the fact that for the first time in a medical field the inference model considers only the similarity condition of the patients, instead of their features. Our results demonstrate the impressive merits of the proposed medical EGP (MedEGP) method, in comparison to the single GP, and Linear Regression (LR) models to predict the FFR index, with well-calibrated uncertainty.Clinical Relevance- This paper establishes an accurate non-invasive approach to predict the FFR for the diagnosis of coronary artery disease.

Fuzzy AHP point factored inference system for detection of cardiovascular disease

The World health organization (WHO) reported that cardiovascular disease is the leading cause of death worldwide, particularly in developing countries. But while diagnosing cardiovascular disease, medical practitioners might have differences of opinions and faced challenging when there is inadequate information and uncertainty of the problem. Therefore, to resolve ambiguity and vagueness in diagnosing disease, a perfect decision-making model is required to assist medical practitioners in detecting the disease at an early stage. Thus, this study designs a fuzzy analytic hierarchy process (FAHP) point-factored inference system to detect cardiovascular disease. The attributes are selected and classified into sub-attributes and point factor scale using the clinical data, medical practitioners, and literature review. Fuzzy AHP is used in calculating the attribute weights, the strings are generated using the Mamdani fuzzy inference system, and the strength of each set of fuzzy rules is calculated by multiplying the attribute weights with the point factor scale. The string weights determine the output ranges of cardiovascular disease. Moreover, the results are validated using sensitivity analysis, and comparative analysis is performed with AHP techniques. The results show that the proposed method outperforms other methods, which are elucidated by the case study.

Site specific prediction of atherosclerotic plaque progression using computational biomechanics and machine learning

Atheromatic plaque progression is considered as a typical pathological condition of arteries and although atherosclerosis is considered as a systemic inflammatory disorder, atheromatic plaque is not uniformly distributed in the arterial tree. Except for the systematic atherosclerosis risk factors, biomechanical forces, LDL concentration and artery geometry contribute to the atherogenesis and atherosclerotic plaque evolution. In this study, we calculate biomechanical forces acting within the artery and we develop a machine learning model for the prediction of atheromatic plaque progression. 1018 coronary sites of 3 mm, derived by 40 individuals, are utilized to develop the model and after the implementation of 4 different tree based prediction schemes, we achieve a prediction accuracy of 0.84. The best accuracy was achieved by the implementation of a tree-based classifier, the Random Forest classifier, after a ranking feature selection methodology. The novel aspect of the proposed methodology is the implementation of machine learning models in order to address the cardiovascular data modeling, aiming to predict the occurrence of an outcome and not to investigate the association of input features.

Machine learning-based coronary artery disease diagnosis: A comprehensive review

Coronary artery disease (CAD) is the most common cardiovascular disease (CVD) and often leads to a heart attack. It annually causes millions of deaths and billions of dollars in financial losses worldwide. Angiography, which is invasive and risky, is the standard procedure for diagnosing CAD. Alternatively, machine learning (ML) techniques have been widely used in the literature as fast, affordable, and noninvasive approaches for CAD detection. The results that have been published on ML-based CAD diagnosis differ substantially in terms of the analyzed datasets, sample sizes, features, location of data collection, performance metrics, and applied ML techniques. Due to these fundamental differences, achievements in the literature cannot be generalized. This paper conducts a comprehensive and multifaceted review of all relevant studies that were published between 1992 and 2019 for ML-based CAD diagnosis. The impacts of various factors, such as dataset characteristics (geographical location, sample size, features, and the stenosis of each coronary artery) and applied ML techniques (feature selection, performance metrics, and method) are investigated in detail. Finally, the important challenges and shortcomings of ML-based CAD diagnosis are discussed.